InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

Current share price for CYP : $0.012 0.001 (7.69%)+

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Activity Report & Appendix 4C 30 Apr 2015 4:46PM $1.000 $0.012 fallen by 98.80%
$3 Commences Further Stage of Stem Cell Manufacturing Program 12 Mar 2015 9:59AM $1.020 $0.012 fallen by 98.82%
$3 Appendix 4D & Half-Year Financial Statements 26 Feb 2015 6:43PM n/a $0.012 n/a
$3 Cynata Achieves Major Stem Cell Manufacturing Milestone 19 Feb 2015 9:46AM $0.700 $0.012 fallen by 98.29%
$3 Trading Halt 17 Feb 2015 9:43AM $0.410 $0.012 fallen by 97.07%
$3 Cynata Engages Leading US Investor Relations Firm 12 Feb 2015 10:06AM $0.375 $0.012 fallen by 96.80%
$3 Cynata Partners with Univeristy of Western Australia 3 Feb 2015 5:52PM n/a $0.012 n/a
$3 Activity Report & Appendix 4C 30 Jan 2015 3:45PM n/a $0.012 n/a
$3 Cynata Listed Options Fully Underwritten 25 Nov 2014 9:17AM $0.370 $0.012 fallen by 96.76%
$3 Australian Patent for Core Cynata Technology 6 Nov 2014 2:56PM $0.365 $0.012 fallen by 96.71%
$3 Activity Report & Appendix 4C 31 Oct 2014 2:51PM $0.350 $0.012 fallen by 96.57%
$3 Cynata Announces Landmark Licensing Deal 18 Sep 2014 10:34AM $0.450 $0.012 fallen by 97.33%
$3 Cynata Initiates European Regulatory Process 3 Sep 2014 10:53AM $0.400 $0.012 fallen by 97%
$3 Appendix 4E & Financial Statements 26 Aug 2014 1:05PM $0.385 $0.012 fallen by 96.88%
$3 Activity Report & Appendix 4C 31 Jul 2014 1:08PM $0.385 $0.012 fallen by 96.88%
$3 CYP Contracts UW to Advance Cymerus Product Development 28 Jul 2014 8:58AM $0.430 $0.012 fallen by 97.21%
$3 Contracts Leading CRO to Conduct Cymerus Preclinical Studies 14 Jul 2014 9:58AM $0.425 $0.012 fallen by 97.18%
$3 Activity Report & Appendix 4C 29 Apr 2014 8:41AM $0.355 $0.012 fallen by 96.62%
$3 Cynata GvHD Partnership with University of Massachusetts 5 Mar 2014 9:48AM $0.380 $0.012 fallen by 96.84%
$3 Appendix 4D & Half-Year Financial Statements 25 Feb 2014 5:17PM $0.370 $0.012 fallen by 96.76%
$3 Cynata Partners with Leading Biologic Product Manufacturer 10 Feb 2014 8:29AM $0.400 $0.012 fallen by 97%
$3 Appendix 4C - quarterly 30 Jan 2014 4:12PM $0.400 $0.012 fallen by 97%
$3 Reinstatement to Official Quotation - 29/11/2013 27 Nov 2013 5:49PM n/a $0.012 n/a

676 - 698 of 698 results

Page 28 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.